000 01500 a2200433 4500
005 20250517034712.0
264 0 _c20160506
008 201605s 0 0 eng d
022 _a1873-5126
024 7 _a10.1016/j.parkreldis.2015.05.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYoritaka, Asako
245 0 0 _aRandomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
_h[electronic resource]
260 _bParkinsonism & related disorders
_cAug 2015
300 _a911-6 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAntioxidants
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuroprotective Agents
_xadministration & dosage
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aPilot Projects
650 0 4 _aTreatment Outcome
650 0 4 _aUbiquinone
_xadministration & dosage
700 1 _aKawajiri, Sumihiro
700 1 _aYamamoto, Yorihiro
700 1 _aNakahara, Toshiki
700 1 _aAndo, Maya
700 1 _aHashimoto, Kazuhiko
700 1 _aNagase, Midori
700 1 _aSaito, Yufuko
700 1 _aHattori, Nobutaka
773 0 _tParkinsonism & related disorders
_gvol. 21
_gno. 8
_gp. 911-6
856 4 0 _uhttps://doi.org/10.1016/j.parkreldis.2015.05.022
_zAvailable from publisher's website
999 _c24963012
_d24963012